Reagan Kazyak Bratten is a Dallas, Texas based Prosthetics. Her current practice location is 2222 Welborn St, Dallas. Patients can reach her at 214-559-5000. Reagan Kazyak Bratten NPI number (Unique professional ID assigned by NPPES) is 1922780576. Reagan Kazyak Bratten is specifically educated and trained to manage comprehensive prosthetic patient care for individuals who have sustained complete or partial limb loss or absence. Prosthetists assess specific patient needs, formulate an appropriate treatment plan, implement the treatment plan and provide follow-up care.
Complete Profile:
Reagan Kazyak Bratten speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Prosthetics
Gender:
Female
Practice Address:
2222 Welborn St, Dallas, Texas, 75219-3924
Phone:
214-559-5000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1922780576
NPI Enumeration Date:
03 Aug, 2023
NPI Last Update On:
09 Apr, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Reagan Kazyak Bratten are as mentioned below.
License Number
Specialization
State
Status
Orthotist
Primary
Prosthetics
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2222 Welborn St, Dallas, Texas
Zip:
75219-3924
Phone Number:
--
Fax Number:
--
Patients can reach Reagan Kazyak Bratten at 2222 Welborn St, Dallas, Texas or can call to book an appointment on 214-559-5000. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.